In vivo models of hepatitis B and C virus infection

FEBS Letters

Volumn , Issue , 2016, Pages 1987-1999

  Winer, Benjamin Y ^a   Ding, Qiang ^a   Gaska, Jenna M ^a   Ploss, Alexander ^a  

^a PRINCETON UNIVERSITY   (United States)

Author keywords

hepatitis B virus; hepatitis C virus; hepatitis delta virus; mouse models; surrogate models

Indexed keywords

CHRONIC HEPATITIS B; DELTA AGENT HEPATITIS; EXPERIMENTAL INFECTION; HEPACIVIRUS; HEPADNAVIRIDAE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS DELTA VIRUS; HOST RANGE; HUMAN; MIXED INFECTION; MOUSE MODEL; NONHUMAN; PEGIVIRUS; PRIORITY JOURNAL; REVIEW; TRANSGENIC MOUSE; TUPAIA; VIRAL TROPISM; VIRUS ENTRY; VIRUS GENOME; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS TRANSMISSION; WOODCHUCK HEPATITIS VIRUS; XENOTRANSPLANTATION;

EID: 84978835928     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1002/1873-3468.12157     Document Type: Review

References (121)

1. Rizzetto M and Ciancio A (2012) Epidemiology of hepatitis D. Semin Liver Dis 32, 211–219.
2. Farci P and Niro GA (2012) Clinical features of hepatitis D. Semin Liver Dis 32, 228–236.
3. Buti M, Homs M, Rodriguez-Frias F, Funalleras G, Jardi R, Sauleda S, Tabernero D, Schaper M and Esteban R (2011) Clinical outcome of acute and chronic hepatitis delta over time: a long-term follow-up study. J Viral Hepat 18, 434–442.
4. Grabowski J and Wedemeyer H (2010) Hepatitis delta: immunopathogenesis and clinical challenges. Dig Dis 28, 133–138.
5. Kwon H and Lok AS (2011) Hepatitis B therapy. Nat Rev Gastroenterol Hepatol 8, 275–284.
6. Dandri M and Lutgehetmann M (2014) Mouse models of hepatitis B and delta virus infection. J Immunol Methods 410, 39–49.
7. Liang TJ and Ghany MG (2013) Current and future therapies for hepatitis C virus infection. N Engl J Med 368, 1907–1917.
8. Pawlotsky JM (2012) New antiviral agents for hepatitis C. F1000 Biol Rep 4, 5.
9. Hoofnagle JH and Sherker AH (2014) Therapy for hepatitis C – the costs of success. N Engl J Med 370, 1552–1553.
10. Man John Law L, Landi A, Magee WC, Lorne Tyrrell D and Houghton M (2013) Progress towards a hepatitis C virus vaccine. Emerg Microbes Infect 2, e79.
11. Seeger C and Mason WS (2000) Hepatitis B virus biology. Microbiol Mol Biol Rev 64, 51–68.
12. Dienstag JL (2008) Hepatitis B virus infection. N Engl J Med 359, 1486–1500.
13. Levrero M, Pollicino T, Petersen J, Belloni L, Raimondo G and Dandri M (2009) Control of cccDNA function in hepatitis B virus infection. J Hepatol 51, 581–592.
14. Belloni L, Pollicino T, De Nicola F, Guerrieri F, Raffa G, Fanciulli M, Raimondo G and Levrero M (2009) Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function. Proc Natl Acad Sci USA 106, 19975–19979.
15. Petersen J, Dandri M, Mier W, Lutgehetmann M, Volz T, von Weizsacker F, Haberkorn U, Fischer L, Pollok JM, Erbes B et al. (2008) Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein. Nat Biotechnol 26, 335–341.
16. Schmitz A, Schwarz A, Foss M, Zhou L, Rabe B, Hoellenriegel J, Stoeber M, Pante N and Kann M (2010) Nucleoporin 153 arrests the nuclear import of hepatitis B virus capsids in the nuclear basket. PLoS Pathog 6, e1000741.
17. Watanabe T, Sorensen EM, Naito A, Schott M, Kim S and Ahlquist P (2007) Involvement of host cellular multivesicular body functions in hepatitis B virus budding. Proc Natl Acad Sci USA 104, 10205–10210.
18. Jiang B, Himmelsbach K, Ren H, Boller K and Hildt E (2015) Subviral hepatitis B virus filaments are released like infectious viral particles via multivesicular bodies. J Virol 90, 3330–3341.
19. Taylor JM (2012) Virology of hepatitis D virus. Semin Liver Dis 32, 195–200.
20. Chang J, Gudima SO, Tarn C, Nie X and Taylor JM (2005) Development of a novel system to study hepatitis delta virus genome replication. J Virol 79, 8182–8188.
21. Hughes SA, Wedemeyer H and Harrison PM (2011) Hepatitis delta virus. Lancet 378, 73–85.
22. Taylor J (1991) Hepatitis delta virus. J Hepatol 13 (Suppl 4), S114–S115.
23. Taylor J and Pelchat M (2010) Origin of hepatitis delta virus. Future Microbiol 5, 393–402.
24. Moradpour D, Penin F and Rice CM (2007) Replication of hepatitis C virus. Nat Rev Microbiol 5, 453–463.
25. Lindenbach BD and Rice CM (2013) The ins and outs of hepatitis C virus entry and assembly. Nat Rev Microbiol 11, 688–700.
26. Targett-Adams P, Boulant S, Douglas MW and McLauchlan J (2010) Lipid metabolism and HCV infection. Viruses 2, 1195–1217.
27. Popescu CI, Rouille Y and Dubuisson J (2011) Hepatitis C virus assembly imaging. Viruses 3, 2238–2254.
28. Gastaminza P, Cheng G, Wieland S, Zhong J, Liao W and Chisari FV (2008) Cellular determinants of hepatitis C virus assembly, maturation, degradation, and secretion. J Virol 82, 2120–2129.
29. Rizzetto M, Canese MG, Gerin JL, London WT, Sly DL and Purcell RH (1980) Transmission of the hepatitis B virus-associated delta antigen to chimpanzees. J Infect Dis 141, 590–602.
30. Bukh J (2004) A critical role for the chimpanzee model in the study of hepatitis C. Hepatology 39, 1469–1475.
31. Thimme R, Wieland S, Steiger C, Ghrayeb J, Reimann KA, Purcell RH and Chisari FV (2003) CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J Virol 77, 68–76.
32. Fields HA, Govindarajan S, Margolis HS, Schable CD, Ebert JW and Maynard JE (1986) Experimental transmission of the delta virus to a hepatitis B chronic carrier chimpanzee with the development of persistent delta carriage. Am J Pathol 122, 308–314.
33. Govindarajan S, Fields HA, Humphrey CD and Margolis HS (1986) Pathologic and ultrastructural changes of acute and chronic delta hepatitis in an experimentally infected chimpanzee. Am J Pathol 122, 315–322.
34. Billerbeck E, de Jong Y, Dorner M, de la Fuente C and Ploss A (2013) Animal models for hepatitis C. Curr Top Microbiol Immunol 369, 49–86.
35. Guidotti LG and Chisari FV (2006) Immunobiology and pathogenesis of viral hepatitis. Annu Rev Pathol 1, 23–61.
36. Bukh J (2012) Animal models for the study of hepatitis C virus infection and related liver disease. Gastroenterology 142, 1279–1287.e3.
37. Ploss A and Rice CM (2009) Towards a small animal model for hepatitis C. EMBO Rep 10, 1220–1227.
38. Altevogt BM, Pankevich DE, Shelton-Davenport MK and Kahn JP, eds (2011) Chimpanzees in Biomedical and Behavioral Research: Assessing the Necessity. Institute of Medicine and National Research Council of the National Academies, Washington, D.C.
39. Xu X, Chen H, Cao X and Ben K (2007) Efficient infection of tree shrew (Tupaia belangeri) with hepatitis C virus grown in cell culture or from patient plasma. J Gen Virol 88, 2504–2512.
40. Walter E, Keist R, Niederost B, Pult I and Blum HE (1996) Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo. Hepatology 24, 1–5.
41. Kock J, Nassal M, MacNelly S, Baumert TF, Blum HE and von Weizsacker F (2001) Efficient infection of primary tupaia hepatocytes with purified human and woolly monkey hepatitis B virus. J Virol 75, 5084–5089.
42. Amako Y, Tsukiyama-Kohara K, Katsume A, Hirata Y, Sekiguchi S, Tobita Y, Hayashi Y, Hishima T, Funata N, Yonekawa H et al. (2009) Pathogenesis of hepatitis C virus infection in Tupaia belangeri. J Virol 84, 303–311.
43. Bukh J, Apgar CL and Yanagi M (1999) Toward a surrogate model for hepatitis C virus: an infectious molecular clone of the GB virus-B hepatitis agent. Virology 262, 470–478.
44. Kapoor A, Simmonds P, Gerold G, Qaisar N, Jain K, Henriquez JA, Firth C, Hirschberg DL, Rice CM, Shields S et al. (2011) Characterization of a canine homolog of hepatitis C virus. Proc Natl Acad Sci USA 108, 11608–11613.
45. Burbelo PD, Dubovi EJ, Simmonds P, Medina JL, Henriquez JA, Mishra N, Wagner J, Tokarz R, Cullen JM, Iadarola MJ et al. (2012) Serology enabled discovery of genetically diverse hepaciviruses in a new host. J Virol 86, 6171–6178.
46. Kapoor A, Simmonds P, Cullen JM, Scheel TK, Medina JL, Giannitti F, Nishiuchi E, Brock KV, Burbelo PD, Rice CM et al. (2013) Identification of a pegivirus (GB virus-like virus) that infects horses. J Virol 87, 7185–7190.
47. Kapoor A, Simmonds P, Scheel TK, Hjelle B, Cullen JM, Burbelo PD, Chauhan LV, Duraisamy R, Sanchez Leon M, Jain K et al. (2013) Identification of rodent homologs of hepatitis C virus and pegiviruses. mBio 4, e00216-13.
48. Firth C, Bhat M, Firth MA, Williams SH, Frye MJ, Simmonds P, Conte JM, Ng J, Garcia J, Bhuva NP et al. (2014) Detection of zoonotic pathogens and characterization of novel viruses carried by commensal Rattus norvegicus in New York City. mBio 5, e01933-14.
49. Pfaender S, Cavalleri JM, Walter S, Doerrbecker J, Campana B, Brown RJ, Burbelo PD, Postel A, Hahn K, Kusuma A et al. (2014) Clinical course of infection and viral tissue tropism of hepatitis C virus-like non-primate hepaciviruses. Hepatology 61, 447–459.
50. Pfaender S, Walter S, Todt D, Behrendt P, Doerrbecker J, Wolk B, Engelmann M, Gravemann U, Seltsam A, Steinmann J et al. (2015) Assessment of cross-species transmission of hepatitis C virus-related non-primate hepacivirus in a population of humans at high risk of exposure. J Gen Virol 96, 2636–2642.
51. Molnar-Kimber KL, Summers J, Taylor JM and Mason WS (1983) Protein covalently bound to minus-strand DNA intermediates of duck hepatitis B virus. J Virol 45, 165–172.
52. Molnar-Kimber KL, Summers JW and Mason WS (1984) Mapping of the cohesive overlap of duck hepatitis B virus DNA and of the site of initiation of reverse transcription. J Virol 51, 181–191.
53. Summers J and Mason WS (1982) Replication of the genome of a hepatitis B–like virus by reverse transcription of an RNA intermediate. Cell 29, 403–415.
54. Summers J, Smith PM and Horwich AL (1990) Hepadnavirus envelope proteins regulate covalently closed circular DNA amplification. J Virol 64, 2819–2824.
55. Tuttleman JS, Pourcel C and Summers J (1986) Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells. Cell 47, 451–460.
56. Wu TT, Coates L, Aldrich CE, Summers J and Mason WS (1990) In hepatocytes infected with duck hepatitis B virus, the template for viral RNA synthesis is amplified by an intracellular pathway. Virology 175, 255–261.
57. Summers J, Smolec JM and Snyder R (1978) A virus similar to human hepatitis B virus associated with hepatitis and hepatoma in woodchucks. Proc Natl Acad Sci USA 75, 4533–4537.
58. Korba BE, Wells FV, Baldwin B, Cote PJ, Tennant BC, Popper H and Gerin JL (1989) Hepatocellular carcinoma in woodchuck hepatitis virus-infected woodchucks: presence of viral DNA in tumor tissue from chronic carriers and animals serologically recovered from acute infections. Hepatology 9, 461–470.
59. Galibert F, Chen TN and Mandart E (1982) Nucleotide sequence of a cloned woodchuck hepatitis virus genome: comparison with the hepatitis B virus sequence. J Virol 41, 51–65.
60. Jacob JR, Korba BE, Cote PJ, Toshkov I, Delaney WET, Gerin JL and Tennant BC (2004) Suppression of lamivudine-resistant B-domain mutants by adefovir dipivoxil in the woodchuck hepatitis virus model. Antiviral Res 63, 115–121.
61. Korba BE, Cote P, Hornbuckle W, Tennant BC and Gerin JL (2000) Treatment of chronic woodchuck hepatitis virus infection in the Eastern woodchuck (Marmota monax) with nucleoside analogues is predictive of therapy for chronic hepatitis B virus infection in humans. Hepatology 31, 1165–1175.
62. Kidd-Ljunggren K, Miyakawa Y and Kidd AH (2002) Genetic variability in hepatitis B viruses. J Gen Virol 83, 1267–1280.
63. Drexler JF, Geipel A, Konig A, Corman VM, van Riel D, Leijten LM, Bremer CM, Rasche A, Cottontail VM, Maganga GD et al. (2013) Bats carry pathogenic hepadnaviruses antigenically related to hepatitis B virus and capable of infecting human hepatocytes. Proc Natl Acad Sci USA 110, 16151–16156.
64. Lucifora J, Arzberger S, Durantel D, Belloni L, Strubin M, Levrero M, Zoulim F, Hantz O and Protzer U (2011) Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection. J Hepatol 55, 996–1003.
65. Yan H, Zhong G, Xu G, He W, Jing Z, Gao Z, Huang Y, Qi Y, Peng B, Wang H et al. (2012) Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. eLife 1, e00049.
66. Yan H, Peng B, Liu Y, Xu G, He W, Ren B, Jing Z, Sui J and Li W (2014) Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide. J Virol 88, 3273–3284.
67. Lempp FA, Mutz P, Lipps C, Wirth D, Bartenschlager R and Urban S (2015) Evidence that hepatitis B virus replication in mouse cells is limited by the lack of a host cell dependency factor. J Hepatol 64, 556–564.
68. Yan H, Peng B, He W, Zhong G, Qi Y, Ren B, Gao Z, Jing Z, Song M, Xu G et al. (2013) Molecular determinants of hepatitis B and D virus entry restriction in mouse sodium taurocholate cotransporting polypeptide. J Virol 87, 7977–7991.
69. Raney AK, Eggers CM, Kline EF, Guidotti LG, Pontoglio M, Yaniv M and McLachlan A (2001) Nuclear covalently closed circular viral genomic DNA in the liver of hepatocyte nuclear factor 1 alpha-null hepatitis B virus transgenic mice. J Virol 75, 2900–2911.
70. He W, Ren B, Mao F, Jing Z, Li Y, Liu Y, Peng B, Yan H, Qi Y, Sun Y et al. (2015) Hepatitis D virus infection of mice expressing human sodium taurocholate co-transporting polypeptide. PLoS Pathog 11, e1004840.
71. Ploss A and Evans MJ (2012) Hepatitis C virus host cell entry. Curr Opin Virol 2, 14–19.
72. Long G, Hiet MS, Windisch MP, Lee JY, Lohmann V and Bartenschlager R (2011) Mouse hepatic cells support assembly of infectious hepatitis C virus particles. Gastroenterology 141, 1057–1066.
73. Vogt A, Scull MA, Friling T, Horwitz JA, Donovan BM, Dorner M, Gerold G, Labitt RN, Rice CM and Ploss A (2013) Recapitulation of the hepatitis C virus life-cycle in engineered murine cell lines. Virology 444, 1–11.
74. Ding Q, von Schaewen M and Ploss A (2014) The impact of hepatitis C virus entry on viral tropism. Cell Host Microbe 16, 562–568.
75. Ploss A, Evans MJ, Gaysinskaya VA, Panis M, You H, de Jong YP and Rice CM (2009) Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature 457, 882–886.
76. Dorner M, Horwitz JA, Robbins JB, Barry WT, Feng Q, Mu K, Jones CT, Schoggins JW, Catanese MT, Burton DR et al. (2011) A genetically humanized mouse model for hepatitis C virus infection. Nature 474, 208–211.
77. Dorner M, Horwitz JA, Donovan BM, Labitt RN, Budell WC, Friling T, Vogt A, Catanese MT, Taniguchi T, Satoh T et al. (2013) Completion of the entire hepatitis C virus life-cycle in genetically humanized mice. Nature 501, 237–241.
78. Zhu Q, Guo JT and Seeger C (2003) Replication of hepatitis C virus subgenomes in nonhepatic epithelial and mouse hepatoma cells. J Virol 77, 9204–9210.
79. Uprichard SL, Chung J, Chisari FV and Wakita T (2006) Replication of a hepatitis C virus replicon clone in mouse cells. Virol J 3, 89.
80. Frentzen A, Huging K, Bitzegeio J, Friesland M, Haid S, Gentzsch J, Hoffmann M, Lindemann D, Zimmer G, Zielecki F et al. (2011) Completion of hepatitis C virus replication cycle in heterokaryons excludes dominant restrictions in human non-liver and mouse liver cell lines. PLoS Pathog 7, e1002029.
81. Moriya K, Fujie H, Shintani Y, Yotsuyanagi H, Tsutsumi T, Ishibashi K, Matsuura Y, Kimura S, Miyamura T and Koike K (1998) The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med 4, 1065–1067.
82. Moriya K, Nakagawa K, Santa T, Shintani Y, Fujie H, Miyoshi H, Tsutsumi T, Miyazawa T, Ishibashi K, Horie T et al. (2001) Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. Cancer Res 61, 4365–4370.
83. Lerat H, Honda M, Beard MR, Loesch K, Sun J, Yang Y, Okuda M, Gosert R, Xiao SY, Weinman SA et al. (2002) Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus. Gastroenterology 122, 352–365.
84. Machida K, Tsukiyama-Kohara K, Seike E, Tone S, Shibasaki F, Shimizu M, Takahashi H, Hayashi Y, Funata N, Taya C et al. (2001) Inhibition of cytochrome c release in Fas-mediated signaling pathway in transgenic mice induced to express hepatitis C viral proteins. J Biol Chem 276, 12140–12146.
85. Disson O, Haouzi D, Desagher S, Loesch K, Hahne M, Kremer EJ, Jacquet C, Lemon SM, Hibner U and Lerat H (2004) Impaired clearance of virus-infected hepatocytes in transgenic mice expressing the hepatitis C virus polyprotein. Gastroenterology 126, 859–872.
86. Alonzi T, Agrati C, Costabile B, Cicchini C, Amicone L, Cavallari C, Rocca CD, Folgori A, Fipaldini C, Poccia F et al. (2004) Steatosis and intrahepatic lymphocyte recruitment in hepatitis C virus transgenic mice. J Gen Virol 85, 1509–1520.
87. Chisari FV (1996) Hepatitis B virus transgenic mice: models of viral immunobiology and pathogenesis. Curr Top Microbiol Immunol 206, 149–173.
88. Guidotti LG, Matzke B, Schaller H and Chisari FV (1995) High-level hepatitis B virus replication in transgenic mice. J Virol 69, 6158–6169.
89. Cui X, Guo JT and Hu J (2015) Hepatitis B virus covalently closed circular DNA formation in immortalized mouse hepatocytes associated with nucleocapsid destabilization. J Virol 89, 9021–9028.
90. Heermann KH, Goldmann U, Schwartz W, Seyffarth T, Baumgarten H and Gerlich WH (1984) Large surface proteins of hepatitis B virus containing the pre-s sequence. J Virol 52, 396–402.
91. Chisari FV, Filippi P, McLachlan A, Milich DR, Riggs M, Lee S, Palmiter RD, Pinkert CA and Brinster RL (1986) Expression of hepatitis B virus large envelope polypeptide inhibits hepatitis B surface antigen secretion in transgenic mice. J Virol 60, 880–887.
92. Kim CM, Koike K, Saito I, Miyamura T and Jay G (1991) HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 351, 317–320.
93. Ye L, Yu H, Li C, Hirsch ML, Zhang L, Samulski RJ, Li W and Liu Z (2015) Adeno-associated virus vector mediated delivery of the HBV genome induces chronic hepatitis B virus infection and liver fibrosis in mice. PLoS One 10, e0130052.
94. Dion S, Bourgine M, Godon O, Levillayer F and Michel ML (2013) Adeno-associated virus-mediated gene transfer leads to persistent hepatitis B virus replication in mice expressing HLA-A2 and HLA-DR1 molecules. J Virol 87, 5554–5563.
95. Yang D, Liu L, Zhu D, Peng H, Su L, Fu YX and Zhang L (2014) A mouse model for HBV immunotolerance and immunotherapy. Cell Mol Immunol 11, 71–78.
96. Huang LR, Wohlleber D, Reisinger F, Jenne CN, Cheng RL, Abdullah Z, Schildberg FA, Odenthal M, Dienes HP, van Rooijen N et al. (2013) Intrahepatic myeloid-cell aggregates enable local proliferation of CD8(+) T cells and successful immunotherapy against chronic viral liver infection. Nat Immunol 14, 574–583.
97. Bissig KD, Wieland SF, Tran P, Isogawa M, Le TT, Chisari FV and Verma IM (2010) Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment. J Clin Invest 120, 924–930.
98. Brehm MA, Jouvet N, Greiner DL and Shultz LD (2013) Humanized mice for the study of infectious diseases. Curr Opin Immunol 25, 428–435.
99. Heckel JL, Sandgren EP, Degen JL, Palmiter RD and Brinster RL (1990) Neonatal bleeding in transgenic mice expressing urokinase-type plasminogen activator. Cell 62, 447–456.
100. Azuma H, Paulk N, Ranade A, Dorrell C, Al-Dhalimy M, Ellis E, Strom S, Kay MA, Finegold M and Grompe M (2007) Robust expansion of human hepatocytes in Fah-/-/Rag2-/-/Il2rg-/- mice. Nat Biotechnol 25, 903–910.
101. Bissig KD, Le TT, Woods NB and Verma IM (2007) Repopulation of adult and neonatal mice with human hepatocytes: a chimeric animal model. Proc Natl Acad Sci USA 104, 20507–20511.
102. de Jong YP, Dorner M, Mommersteeg MC, Xiao JW, Balazs AB, Robbins JB, Winer BY, Gerges S, Vega K, Labitt RN et al. (2014) Broadly neutralizing antibodies abrogate established hepatitis C virus infection. Sci Transl Med 6, 254ra129.
103. Grompe M (2001) The pathophysiology and treatment of hereditary tyrosinemia type 1. Semin Liver Dis 21, 563–571.
104. Al-Dhalimy M, Overturf K, Finegold M and Grompe M (2002) Long-term therapy with NTBC and tyrosine-restricted diet in a murine model of hereditary tyrosinemia type I. Mol Genet Metab 75, 38–45.
105. Hasegawa M, Kawai K, Mitsui T, Taniguchi K, Monnai M, Wakui M, Ito M, Suematsu M, Peltz G, Nakamura M et al. (2011) The reconstituted ‘humanized liver’ in TK-NOG mice is mature and functional. Biochem Biophys Res Commun 405, 405–410.
106. Mercer DF, Schiller DE, Elliott JF, Douglas DN, Hao C, Rinfret A, Addison WR, Fischer KP, Churchill TA, Lakey JR et al. (2001) Hepatitis C virus replication in mice with chimeric human livers. Nat Med 7, 927–933.
107. Kosaka K, Hiraga N, Imamura M, Yoshimi S, Murakami E, Nakahara T, Honda Y, Ono A, Kawaoka T, Tsuge M et al. (2013) A novel TK-NOG based humanized mouse model for the study of HBV and HCV infections. Biochem Biophys Res Commun 441, 230–235.
108. Dandri M, Burda MR, Torok E, Pollok JM, Iwanska A, Sommer G, Rogiers X, Rogler CE, Gupta S, Will H et al. (2001) Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus. Hepatology 33, 981–988.
109. Meuleman P, Libbrecht L, De Vos R, de Hemptinne B, Gevaert K, Vandekerckhove J, Roskams T and Leroux-Roels G (2005) Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera. Hepatology 41, 847–856.
110. Lindenbach BD, Meuleman P, Ploss A, Vanwolleghem T, Syder AJ, McKeating JA, Lanford RE, Feinstone SM, Major ME, Leroux-Roels G et al. (2006) Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro. Proc Natl Acad Sci USA 103, 3805–3809.
111. Giersch K, Helbig M, Volz T, Allweiss L, Mancke LV, Lohse AW, Polywka S, Pollok JM, Petersen J, Taylor J et al. (2014) Persistent hepatitis D virus mono-infection in humanized mice is efficiently converted by hepatitis B virus to a productive co-infection. J Hepatol 60, 538–544.
112. Belloni L, Allweiss L, Guerrieri F, Pediconi N, Volz T, Pollicino T, Petersen J, Raimondo G, Dandri M and Levrero M (2012) IFN-alpha inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome. J Clin Invest 122, 529–537.
113. Strom SC, Davila J and Grompe M (2010) Chimeric mice with humanized liver: tools for the study of drug metabolism, excretion, and toxicity. Methods Mol Biol 640, 491–509.
114. Strick-Marchand H, Dusseaux M, Darche S, Huntington ND, Legrand N, Masse-Ranson G, Corcuff E, Ahodantin J, Weijer K, Spits H et al. (2015) A novel mouse model for stable engraftment of a human immune system and human hepatocytes. PLoS One 10, e0119820.
115. Shultz LD, Brehm MA, Garcia-Martinez JV and Greiner DL (2012) Humanized mice for immune system investigation: progress, promise and challenges. Nat Rev Immunol 12, 786–798.
116. Haridass D, Yuan Q, Becker PD, Cantz T, Iken M, Rothe M, Narain N, Bock M, Norder M, Legrand N et al. (2009) Repopulation efficiencies of adult hepatocytes, fetal liver progenitor cells, and embryonic stem cell-derived hepatic cells in albumin-promoter-enhancer urokinase-type plasminogen activator mice. Am J Pathol 175, 1483–1492.
117. Washburn ML, Bility MT, Zhang L, Kovalev GI, Buntzman A, Frelinger JA, Barry W, Ploss A, Rice CM and Su L (2011) A humanized mouse model to study hepatitis C virus infection, immune response, and liver disease. Gastroenterology 140, 1334–1344.
118. Bility MT, Cheng L, Zhang Z, Luan Y, Li F, Chi L, Zhang L, Tu Z, Gao Y, Fu Y et al. (2014) Hepatitis B virus infection and immunopathogenesis in a humanized mouse model: induction of human-specific liver fibrosis and M2-like macrophages. PLoS Pathog 10, e1004032.
119. Carpentier A, Tesfaye A, Chu V, Nimgaonkar I, Zhang F, Lee SB, Thorgeirsson SS, Feinstone SM and Liang TJ (2014) Engrafted human stem cell-derived hepatocytes establish an infectious HCV murine model. J Clin Invest 124, 4953–4964.
120. Gutti TL, Knibbe JS, Makarov E, Zhang J, Yannam GR, Gorantla S, Sun Y, Mercer DF, Suemizu H, Wisecarver JL et al. (2014) Human hepatocytes and hematolymphoid dual reconstitution in treosulfan-conditioned uPA-NOG mice. Am J Pathol 184, 101–109.
121. Wilson EM, Bial J, Tarlow B, Bial G, Jensen B, Greiner DL, Brehm MA and Grompe M (2014) Extensive double humanization of both liver and hematopoiesis in FRGN mice. Stem Cell Res 13, 404–412.